Wendy Diller
Co-Chief, Business Bureau, Biopharma Group Elsevier Business Intelligence

Wendy Diller is a bureau chief in the Biopharma Group at Elsevier Business Intelligence (formerly FDC-Windhover), and specializes in analyzing and writing about corporate strategy, business development, and commercial issues in the biopharma industry. From 2005 to 2008, she worked at Standard & Poor’s Equity Research Services, writing on and analyzing macro political, regulatory and economic trends related to the U.S. and global biotechnology and pharmaceutical industries, and for 14 years prior to that, she was a writer and analyst at Windhover Information, publishers of IN VIVO and Start Up magazines and Windhover’s Strategic Transactions Database.  As a key member of the editorial team, she helped build the company into a world-class provider of sophisticated healthcare business information, which Elsevier bought in 2008. Ms. Diller holds a B.A. from Middlebury College, an M.S.J. from Northwestern University, and an M.B.A. from New York University Graduate School of Business.